The Board of Trustees of the Leland Stanford Junior University
发明人:
Ahmad Salehi,Brian Medina,Van Dang,Devsmita Das
申请号:
US15866344
公开号:
US20180360744A1
申请日:
2018.01.09
申请国别(地区):
US
年份:
2018
代理人:
摘要:
A method of improving cognition in a patient with Down syndrome, which entails intranasally administering one or more β2-ADR agonists or pharmaceutically-acceptable salts of either or both to the patient in an amount and with a frequency effective to improve cognition of the patient as measured contextual learning tests.